Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40428-87-3 | MDL No. : | MFCD00134684 |
Formula : | C11H14O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JYTHSLNJXAEHQT-UHFFFAOYSA-N |
M.W : | 162.23 | Pubchem ID : | 3085492 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 51.22 |
TPSA : | 17.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.22 cm/s |
Log Po/w (iLOGP) : | 2.33 |
Log Po/w (XLOGP3) : | 2.91 |
Log Po/w (WLOGP) : | 3.01 |
Log Po/w (MLOGP) : | 2.69 |
Log Po/w (SILICOS-IT) : | 3.17 |
Consensus Log Po/w : | 2.82 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.92 |
Solubility : | 0.196 mg/ml ; 0.00121 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.93 |
Solubility : | 0.191 mg/ml ; 0.00118 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.54 |
Solubility : | 0.0463 mg/ml ; 0.000285 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.05 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | Stage #1: With n-butyllithium In tetrahydrofuran at -60℃; for 0.5 h; Inert atmosphere Stage #2: at -30℃; for 3 h; Inert atmosphere |
Into a 500-mL round-bottom flask purged and maintained with an inert atmosphere of N2 was placed a solution of 1-bromo-3- (propan-2-yl)benzene (5.0 g, 25.11 mmol, 1.00 equiv) in THF (250 mL). This was followed by the addition of n-BuLi (20 mL, 2.00 equiv) dropwise with stirring at -60 °C. The mixture was stirred at -60°C for 30 mm. To this was added N-methoxy-N-methylacetamide (3.9 g, 37.82 mmol, 1.50 equiv) dropwise with stirring at -30 °C. The resulting solution was stirred for 3 h at -30 °C in a liquid N2 bath. The reaction was then quenched by the addition of 20 mL of water. The resulting solution was diluted with 200 mL of EtOAc, washed with 2x100 mL of brine, dried over anhydrous Na2SO4 and concentrated under vacuum. The residue was applied onto a silica gel column with EtOAc/petroleum ether (1:10). This resulted in 2.7 g (66percent) of the title product as colorless oil. |
[ 6136-71-6 ]
1-(3-(tert-Butyl)phenyl)ethanone
Similarity: 0.97
[ 408359-52-4 ]
1-(3-Cyclopropylphenyl)ethanone
Similarity: 0.94
[ 6921-45-5 ]
1-(4-Cyclopropylphenyl)ethanone
Similarity: 0.94
[ 21145-77-7 ]
1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone
Similarity: 0.91
[ 6136-71-6 ]
1-(3-(tert-Butyl)phenyl)ethanone
Similarity: 0.97
[ 408359-52-4 ]
1-(3-Cyclopropylphenyl)ethanone
Similarity: 0.94
[ 6921-45-5 ]
1-(4-Cyclopropylphenyl)ethanone
Similarity: 0.94
[ 21145-77-7 ]
1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone
Similarity: 0.91